CellXplore

CellXplore is a biotechnology company and contract research organization specializing in proteomics-based biomarker discovery and the development of cancer diagnostics. The company utilizes a proprietary platform that integrates high-resolution protein separation with mass spectrometry to identify unique protein expression patterns associated with various malignancies. By focusing on the functional proteome, CellXplore aims to identify novel therapeutic targets and improve the accuracy of early disease detection for high-impact cancers such as breast, lung, and ovarian cancer. In addition to its internal research programs, the company provides specialized proteomic services to pharmaceutical and academic partners, including protein profiling and post-translational modification analysis. Their approach seeks to bridge the gap between genomic data and clinical application to advance personalized medicine. CellXplore's technology is designed to facilitate the discovery of clinically relevant biomarkers that are not apparent through traditional genomic analysis alone.